Seeing Is Believing

Currently out of the existing stock ratings of Aydin Huseynov, 49 are a BUY (84.48%), 9 are a HOLD (15.52%).
Analyst Aydin Huseynov, currently employed at LADENBURG, carries an average stock price target met ratio of 36.9% that have a potential upside of 52.56% achieved within 259 days.
Aydin Huseynov’s has documented 108 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NXTC, NextCure at 06-Nov-2025.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 5/21/2020. The price target of $336 was fulfilled within 35 days with a profit of $165.12 (96.63%) receiving and performance score of 27.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$1.97 (6566.67%)
$2
3 years 5 days ago
(15-Nov-2022)
3/4 (75%)
$-0.38 (-15.97%)
53
Buy
$8
$7.97 (26566.67%)
3 years 2 months 22 days ago
(29-Aug-2022)
0/1 (0%)
$4.17 (108.88%)
Buy
$140
$139.97 (466566.66%)
5 years 6 months 9 days ago
(11-May-2020)
0/2 (0%)
$3.2 (2.34%)
Buy
$340
$339.95 (679900.00%)
$240
8 years 7 months 22 days ago
(29-Mar-2017)
3/3 (100%)
$110.33 (71.65%)
163
Which stock is Aydin Huseynov is most bullish on?
What Year was the first public recommendation made by Aydin Huseynov?